Back to News
Market Impact: 0.2
Realbotix Consensus Price Target Cut by 20.53% to $0.42
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year analyst price target for Realbotix was revised down 20.53% to $0.42 per share from $0.53, with the prior estimate dated January 13, 2026. The figures are aggregate targets compiled from various researchers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
XBOT-0.45
More News
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Goldman says these top tech stocks have plenty of upside ahead of earnings
- ProPetro’s 49% decline: how Fair Value spotted the warning signs
- Persistent Oil Prices Threaten Inflation Outlook
- Could France’s debt crisis spread across Europe?
- Japan Post Holdings sells $1.37M in Aflac stock